Upon abstract acceptance, all posters must be uploaded and recorded on VoiceThread by January 26, 2026 at 5 p.m. All posters that are narrated on VoiceThread by the deadline will be officially listed ...
DUBLIN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment ...
Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today ...
Are you ready to showcase your research and sharpen your communication skills? Join us for the upcoming 2025 CCTS Translational Science Symposium held on October 30th-October 31st. On October 30th, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ...
Leaders don’t need more slides—they need more sensemaking. The future of presentations is clarity, story, and presence, not polish. Do you recall sitting through a meeting where the slides just wouldn ...
Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results